The life and times of ivermectin — a success story

@article{mura2004TheLA,
  title={The life and times of ivermectin — a success story},
  author={Satoshi Ōmura and Andy Crump},
  journal={Nature Reviews Microbiology},
  year={2004},
  volume={2},
  pages={984-989}
}
  • S. Ōmura, A. Crump
  • Published 1 December 2004
  • Medicine, Biology
  • Nature Reviews Microbiology
Since its introduction more than 20 years ago, ivermectin has proved to be one of the most successful therapeutic drugs in veterinary medicine, as well as the basis of one of the most successful public-health programmes of the past century. The drug arose from a unique international collaboration between the public and private sectors. The development process also incorporated the world's first and largest drug-donation programme and involved a unique association between governments, non… Expand
Ivermectin: 25 years and still going strong.
  • S. Ōmura
  • Medicine
  • International journal of antimicrobial agents
  • 2008
TLDR
This remarkable compound has improved the lives and productivity of billions of humans, livestock and pets around the globe, and promises to help consign to the history books two devastating and disfiguring diseases that have plagued people throughout the tropics for generations--while new uses for it are continually being found. Expand
Ivermectin 20 years on: maturation of a wonder drug.
  • T. Geary
  • Biology, Medicine
  • Trends in parasitology
  • 2005
TLDR
Ivermectin has been on the veterinary market for almost a quarter of a century and has been approved for human use for 18 years, and has earned the title of "wonder drug". Expand
Ivermectin: panacea for resource-poor communities?
The 2014 Gairdner Global Health Award was conferred for discovery of the unique microorganism that is the sole source of the endectocidal avermectins, and the Public sector/Private sector PartnershipExpand
Ivermectin and malaria control
TLDR
Increasing attention is now being paid to the potential offered by re-formulating and re-purposing ivermectin to function as a feed-though mosquitocidal tool, which will provide a comprehensively beneficial weapon, for the anti-malarial armamentarium, as well as for probably improving the impact on existing target diseases. Expand
Ivermectin, ‘Wonder drug’ from Japan: the human use perspective
  • A. Crump, S. Ōmura
  • Biology, Medicine
  • Proceedings of the Japan Academy. Series B, Physical and biological sciences
  • 2011
TLDR
This paper looks in depth at the events surrounding ivermectin’s passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a “wonder” drug. Expand
New medicines from nature's armamentarium.
  • A. Crump
  • Medicine
  • Trends in parasitology
  • 2006
TLDR
Participants at the 9th Max Tishler Memorial Symposium were told about several new advances in the search for new anti-infective drugs derived from natural sources and were able to learn how one of the most effective drugs ever, ivermectin, made its way through what was, at the time, uncharted territory. Expand
Opportunities and Challenges in Antiparasitic Drug Discovery
TLDR
Challenges and opportunities for antiparasitic drug discovery are considered, highlighting some of the progress that has been made in recent years, partly through scientific advances, but also by more effective partnership between the public and private sectors. Expand
The onchocerciasis chronicle: from the beginning to the end?
TLDR
The history of onchocerciasis is looked at, from its discovery through to 2025, by which time it is projected that the disease will have been eliminated as a public health problem, except in a handful of sub-Saharan countries, where it should be well on the way towards elimination. Expand
Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations
  • A. Crump
  • Medicine
  • The Journal of Antibiotics
  • 2017
TLDR
ivermectin is continuing to surprise and excite scientists, offering more and more promise to help improve global public health by treating a diverse range of diseases, with its unexpected potential as an antibacterial, antiviral and anti-cancer agent being particularly extraordinary. Expand
Ivermectin: a complimentary weapon against the spread of malaria?
  • H. Alout, B. Foy
  • Biology, Medicine
  • Expert review of anti-infective therapy
  • 2017
TLDR
The use of ivermectin to control malaria transmission will necessitate development and testing of long-lasting formulations or repeated treatments, and implementation of these treatments with other disease control tools may increase the chance of successful and sustained control. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 62 REFERENCES
The delivery of ivermectin (Mectizan).
TLDR
The present challenge is sustaining the methods that have brought success so far, and making them part of health services and disease control programmes in some of the world's most impoverished and unstable areas. Expand
Review: The delivery of ivermectin (Mectizan®)
TLDR
The present challenge is sustaining the methods that have brought success so far, and making them part of health services and disease control programmes in some of the world's most impoverished and unstable areas. Expand
Ivermectin and Abamectin
TLDR
This comprehensive monograph satisfies the need for a review and synthesis of current knowledge about the use of ivermectin and abamectin in crop protection as well as in cattle, sheep, swine, horses, dogs, cats, birds, fish, reptiles, and in man. Expand
The status of ivermectin in the treatment of human onchocerciasis.
  • H. Taylor, B. Greene
  • Biology, Medicine
  • The American journal of tropical medicine and hygiene
  • 1989
TLDR
In patients with onchocerciasis, a single oral dose of ivermectin (150 micrograms/kg) repeated once a year leads to a marked reduction in skin microfilaria counts and ocular involvement. Expand
Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment.
TLDR
It is suggested that ivermectin is the first practical drug suitable for mass treatment campaigns to control human onchocerciasis and well accepted, and effective in reducing microfilarial loads. Expand
Ivermectin: a potent new antiparasitic agent.
TLDR
Ivermectin is the 22,23-dihydro derivative of avermECTin B1, a macrocyclic lactone produced by an actinomycete, Streptomyces avermitilis, in commercial use in various countries for the treatment and control of parasites in cattle, horses, and sheep, and is expected to become available for use in swine and dogs. Expand
Large scale ivermectin distribution and its epidemiological consequences.
TLDR
Ivermectin treatment appears to be the most appropriate method for control of recrudescence of infection in an area where the parasite reservoir has been virtually eliminated by vector control, such as in the core area of the OCP. Expand
Eliminating onchocerciasis as a public health problem
  • B. Thylefors
  • Medicine
  • Tropical medicine & international health : TM & IH
  • 2004
TLDR
The establishment of the MDP and its work through a broad partnership from UN-agencies and Ministries of Health to affected communities has allowed for the present success and will also go a long way to achieve global control of onchocerciasis which is now within reach. Expand
Economic evaluation of Mectizan distribution
TLDR
Pending the development of an effective macrofilaricide, the distribution of ivermectin will remain a public health priority into the foreseeable future. Expand
The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana.
TLDR
The study reports the changes in skin microfilarial loads during the first 5 years of annual treatment in the holoendemic focus of Asubende in Ghana, which was the largest trial area and which also had the longest series of follow-up surveys, and emphasizes that even a single treatment with ivermectin has a significant medium-term impact on microfilerial loads. Expand
...
1
2
3
4
5
...